Vertex Pharmaceuticals Incorporated (FRA:VX1)
391.80
-3.90 (-0.99%)
At close: Dec 5, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €99.34 billion as of December 5, 2025. Its market cap has decreased by -12.70% in one year.
Market Cap
99.34B
Enterprise Value
90.59B
Revenue
9.99B
Ranking
n/a
PE Ratio
31.71
Stock Price
€391.80
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 99.34B, an increase of 134,353.39%. That is a compound annual growth rate of 23.30%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |